Myriad Genetics Inc (NASDAQ:MYGN) is held by 213 institutional investors per 13F filings through December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 424,423 | 2.85% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 342,856 | 4.35% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 158,705 | 14.78% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -177,652 | -37.05% | $0.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 0 | 1,951,831 | 41.11% | $0.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 0 | 623,000 | 103.83% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 1,389 | 142.46% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 990,075 | 19.90% | $0.00 |
| Nuveen, LLC | 31 Dec, 2025 | 0 | 465,670 | 64.24% | $0.00 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 246,748 | 38.61% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | -53,943 | -1.18% | $0.00 |
| Qube Research & Technologies Ltd | 31 Dec, 2025 | 0 | -313,381 | -26.41% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | -9,136 | -0.25% | $0.00 |
| Walleye Capital LLC | 31 Dec, 2025 | 0 | 277,319 | 69.35% | $0.00 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31 Dec, 2025 | 0 | -172,534 | -7.06% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | 147,045 | 29.85% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 6,123 | 0.28% | $0.00 |
| Trexquant Investment LP | 31 Dec, 2025 | 0 | 143,203 | 35.86% | $0.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 0 | 8,503 | 0.40% | $0.00 |